Welcome to our dedicated page for Xenous Hldgs SEC filings (Ticker: XITO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Xenous Hldgs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Xenous Hldgs's regulatory disclosures and financial reporting.
Xenous Holdings, Inc. remains a development-stage shell with no operations, no assets and no cash as of December 31, 2025. Total liabilities were $950,127, all current, resulting in an equal stockholders’ deficit and working capital deficit.
The company reported a net loss of $15,519 for the quarter and $46,505 for the nine months ended December 31, 2025, similar to the prior year and driven mainly by professional and administrative fees. Accumulated deficit reached $1,260,927.
Operations are financed entirely through non‑interest‑bearing, on‑demand advances from its controlling shareholder, with $926,283 due to Ms. Tan Lee San as of December 31, 2025. Management and auditors highlight substantial doubt about the company’s ability to continue as a going concern.
The stated strategy is to identify and acquire an operating business, with ongoing due diligence on a Malaysia-based Aquilaria-focused agriculture company expected to conclude in the second half of calendar 2026.
Xenous Holdings, Inc. submitted a Form 12b-25 notifying the SEC that it could not complete and file its Quarterly Report on Form 10-Q for the period ended December 31, 2025 without unreasonable effort and expense.
The notice is signed by Jonathan Chan Ye Earn, Chief Executive Officer, dated February 18, 2026. The filing states contact information as 852-3923-1188.
Xenous Holdings, Inc. (XITO) filed its quarterly report for the period ended September 30, 2025, showing it remains a non‑operating shell company with ongoing losses and a significant capital deficit. The company reported a net loss of $30,986 for the six months ended September 30, 2025, similar to the $31,155 loss a year earlier, and has accumulated deficit of $1,245,408.
Xenous reported no assets or cash, while current liabilities reached $934,608, resulting in a stockholders’ deficit and a working capital deficit of the same amount. Operations are funded entirely through related‑party advances; during the six‑month period, $31,445 was advanced, and the total due to the new controlling shareholder, Ms. Tan Lee San, was $911,163 as of September 30, 2025. The company’s auditors and management highlight substantial doubt about its ability to continue as a going concern, though management is pursuing a potential acquisition of a Malaysia‑based agricultural business and continuing due diligence.
Xenous Holdings, Inc. filed a Form 12b-25 to notify that its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025 will be filed late. The company states it was unable to meet the original deadline without unreasonable effort or expense because it needs additional time to complete and finalize the financial statements for that quarter.
The company indicates that it expects to file the Form 10-Q as soon as possible, signaling that the delay is intended to be temporary while the reporting process is finished.